| 摘要 |
The invention relates to the field of therapeutic chemistry. It relates to novel pharmaceutical compositions intended, in particular, for ocular application, which contain as active principle at least one compound having a 19-nor steroid structure, corresponding to the general formula I <IMAGE> in which Z is defined as in the description R1 represents a hydroxyl, alkoxy, acyloxy or alkyl radical and R2 represents hydrogen or a lower alkyl radical in combination or mixed with a pharmaceutically acceptable, non-toxic, inert excipient or vehicle. <IMAGE>
|
